Post Doctorate
Lin Shuai

 


Personal Profile

2021.4-Now, Institute of Metabolism & Intergative Biology Fudan University, Postdoctoral fellow

2018.7-2021.3, Shanghai Institute of Materia Medica, Postdoctoral fellow

2013.9-2018.6, University of Chinese Academy of Sciences, Pharmocology, Ph.D.

2009.9-2013.6, Nanjing University, Life sciences, B.S.

Research interests

Mechanism study of obesity and associated metabolic diseases and anti-obesity drug discovery.

Honors and Awards

2016-2017 "Merit Student" of University of Chinese Academy of Sciences

2019-2021 China Postdoctoral Science Foundation Grant

Selected Publications

  1. Lin Shuai#, Bo-Han Li#, Hao-Wen Jiang, Jia Li*, and Jing-Ya Li*. DOT1L regulates thermogenic adipocyte differentiation and function via modulating H3K79 methylation. Diabetes, 2021, 70: 1-17.(co-first author)

  2. Lin Shuai#, Li-Na Zhang#, Bo-Han Li#, Chun-Lan Tang, Ling-Yan Wu, Jia Li*, and Jing-Ya Li*. SIRT5 regulates brown adipocyte differentiation and browning of subcutaneous white adipose tissue. Diabetes, 2019, 68: 1449-1461.(co-first author)

  3. Litong Nie#, Lin Shuai#, Mingrui Zhu#, Ping Liu, Zhi-Fu Xie, Shangwen Jiang, Hao-Wen Jiang, Jia Li, Yingming Zhao, Jing-Ya Li*, Minjia Tan*. The Landscape of Histone Modifications in a High-Fat Diet-induced-Obese (DIO) Mouse Model. Mol Cell Proteomics, 2017, 16(7): 1324-1334. (co-first author)

  4. Shi-Wei Mao#, Lin Shuai#, Hai-Bing He#, Na Pan, Li-Xin Gao, Li-Fang Yu, Jia Li, Jing-Ya L*i and Fan Yang*. Synthesis and biological evaluation of novel 2,3-pyrazole ring-substituted-4,4-dimethyl lithocholic acid derivatives as selective protein tyrosine phosphatase 1B (PTP1B) inhibitors with cellular efficacy. RSC Adv, 2015, 5: 106551. (co-first author)